Navigation Links
Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Date:12/26/2008

in the development and regrowth of the hair follicle,(i) by increasing the percent of hairs in, and the duration of, the anagen or growth phase.

"As an oculoplastic surgeon who has treated both medical eye conditions as well as aesthetic needs, I have extensive knowledge of and experience with the established therapeutic safety profile for bimatoprost," said Steven Fagien, M.D., F.A.C.S., in private practice at Aesthetic Eyelid Plastic Surgery in Boca Raton, Florida, and LATISSE(TM) clinical investigator. "In the clinical study with LATISSE(TM), I observed statistically significant differences in eyelash growth and resulting patient satisfaction. Now that LATISSE(TM) is FDA approved, I look forward to prescribing it to my patients who will enjoy the benefits of more prominent eyelashes while I remain confident in the treatment's favorable safety profile."

LATISSE(TM) will be available in the United States by prescription only and is subject to all U.S. guidelines applicable to dispensing a prescription product. Based on today's FDA approval, Allergan expects to launch the product nationwide in the first quarter of 2009. Doctors and consumers are encouraged to visit www.latisse.com for further product and prescribing information.

Allergan estimates global peak sales of LATISSE(TM) could exceed $500 million per year. As the exclusive U.S. and foreign patent owner, Allergan obtains the rights to the use of bimatoprost and other prostaglandins and prostaglandin analogs as a treatment to stimulate eyelash growth.

LATISSE(TM) Clinical Development Program

In the pivotal Phase III study, 278 healthy adult patients with no active ocular disease and with baseline minimal or moderate eyelash prominence were randomized to apply either LATISSE(TM) or vehicle to both upper eyelid margins once daily for 16 weeks. The prima
'/>"/>

SOURCE Allergan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Video: Keppra XR(TM) Approved in the U.S.
10. Video: Fortune 1000 Executives: New President Must Fix Education Gap
11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Ambassador to Speak at Economic Cl...anada (Vocus) November 25, 2009 -- Ambassador to S...vid Appia, French Ambassador for International Inv...nce Agency ,To view a biography of David Appia go ...or Appia is available to meet with press to discus...
(Date:11/25/2009)...NDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBioscien...art,Pharm.D.,presidentandchiefexecutiveofficer,wil...rence. , ,Presentationdetailsareasfollows:,Piper...,December1,2009,Time:2:00p.m.EasternTime,Location:...ttp://www.corporate-ir.net/ireye/,target=,_blank,...
(Date:11/24/2009)...NTACRUZ,Calif.,Nov.24/PRNewswire/--Twomoreprestigi...,sleadingonlinejobboardandcareerssiteforlifescienc...rsityarenowmembersofthejobboard,joining28othermajo...d, www.biocareercenter.com ,isonlyforpost-graduate...ncecareersitesontheInternet,BioCareerCenteristheon...
(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...irstCall/ -- AMAG,Pharmaceuticals, Inc. (Nasdaq: ... Chinese biotechnology company, today announced th...greement for ferumoxytol, an intravenous,iron repl... iron deficiency,anemia in chronic kidney disease ...towards expanding the potential use of,ferumoxytol...
...,(Euronext Paris: COX) today announced that Damian...elopment, will be leaving the company on May 30th,...ical stage,biopharmaceutical company. Damian,s res...ce President Commercial Affairs and Gavin Spencer,...arufi, Chairman and CEO of NicOx, commented: "Sinc...
....,(OTC Bulletin Board: CBAI), the umbilical cord b...ordblood-america.com ) focused on bringing the li...onwide and internationally,today reported that Cor...cquired in October 2006, had its first operational...ding March 31, 2008., CorCell, at the time of the...
Other Biology Technology:AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 2AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China 3NicOx Announces Departure of Damian Marron for CEO Position 2Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable 2
(Date:11/23/2009)..., Mass. November 23, 2009 Applied mathematicians...osta lancifolia ), a characteristic long leaf with...ipples along the edges. The simple cause of the li...om bending during differential growthwas revealed ...oam ribbons. , Haiyi Liang, a postdoctoral stude...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
(Date:11/23/2009)...T Current research suggests that a common oral ba...lated report by Nichols et al, "Unique Lipids from... TLR2 Ligands Capable of Enhancing Autoimmunity," ...n Journal of Pathology . , Multiple sclerosis (M...brain and spinal cord, affects nearly 1 in 700 peo...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Osteotech Announces Second Quarter 2009 Financial Results Release and Conference Call 52614 1Osteotech Announces Second Quarter 2009 Financial Results Release and Conference Call 52614 2Pennsylvanians With Disabilities Call for an End to Institution Only Options 52611 1Pennsylvanians With Disabilities Call for an End to Institution Only Options 52611 2Omnicell Announces Second Quarter 2009 Results 52608 1Omnicell Announces Second Quarter 2009 Results 52608 2Omnicell Announces Second Quarter 2009 Results 52608 3Omnicell Announces Second Quarter 2009 Results 52608 4Omnicell Announces Second Quarter 2009 Results 52608 5Omnicell Announces Second Quarter 2009 Results 52608 6Omnicell Announces Second Quarter 2009 Results 52608 7Omnicell Announces Second Quarter 2009 Results 52608 8Omnicell Announces Second Quarter 2009 Results 52608 9Omnicell Announces Second Quarter 2009 Results 52608 10Omnicell Announces Second Quarter 2009 Results 52608 11Omnicell Announces Second Quarter 2009 Results 52608 12
...able in German . , Munich/Halle(Saale). A novel ...ge areas cost-effectively the first time. The pate...sion, according to which certain gases pass throug... sensor it is possible to measure an average gas c... influencing or distorting conditions in the measu...
... -- Dr. Thomas Cellucci, chief commercialization o...S) Science and Technology (S&T) Directorate; and P...will be featured Business Panel speakers at the 20...or Homeland Security. , The eighth-annual confere... in Waltham, Mass. For more information and to reg...
...gain more or less than recommended amounts of weig...k of problems for both themselves and their child,...l-University of North Carolina at Chapel Hill Evid...as supported by the U.S. Department of Health and ...Quality (AHRQ) in partnership with the American Di...
Other Biology News:New gas sensors for monitoring carbon dioxide sinks 2IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization 2Too much or too little weight gain poses risks to pregnant mothers, babies 2
SEQUENASE PCR PRODUCT PRE-SEQU from GE Healthcare, formerly Amersham Biosciences
Cynomolgus macaque serum from Alpha Genesis, Inc.
Anti-Foam Reagent from Promega
Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain
Biology Products: